These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Zonisamide: review of its use in epilepsy therapy. Zareba G Drugs Today (Barc); 2005 Sep; 41(9):589-97. PubMed ID: 16341290 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and drug interactions with zonisamide. Sills G; Brodie M Epilepsia; 2007 Mar; 48(3):435-41. PubMed ID: 17319920 [TBL] [Abstract][Full Text] [Related]
8. Clinical pharmacology and therapeutic drug monitoring of zonisamide. Mimaki T Ther Drug Monit; 1998 Dec; 20(6):593-7. PubMed ID: 9853971 [TBL] [Abstract][Full Text] [Related]
9. Zonisamide: new drug. No advantage in refractory partial epilepsy. Prescrire Int; 2007 Jun; 16(89):95-7. PubMed ID: 17582922 [TBL] [Abstract][Full Text] [Related]
10. Three new drugs for epilepsy: levetiracetam, oxcarbazepine, and zonisamide. Leppik IE J Child Neurol; 2002 Jan; 17 Suppl 1():S53-7. PubMed ID: 11918464 [TBL] [Abstract][Full Text] [Related]
11. Zonisamide in epilepsy: a pilot study. Wilensky AJ; Friel PN; Ojemann LM; Dodrill CB; McCormick KB; Levy RH Epilepsia; 1985; 26(3):212-20. PubMed ID: 4006880 [TBL] [Abstract][Full Text] [Related]
15. Zonisamide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy. Peters DH; Sorkin EM Drugs; 1993 May; 45(5):760-87. PubMed ID: 7686468 [TBL] [Abstract][Full Text] [Related]
18. Zonisamide: a review of its use in the management of partial seizures in epilepsy. Frampton JE; Scott LJ CNS Drugs; 2005; 19(4):347-67. PubMed ID: 15813651 [TBL] [Abstract][Full Text] [Related]
19. Long-term safety and efficacy of zonisamide versus carbamazepine monotherapy for treatment of partial seizures in adults with newly diagnosed epilepsy: results of a phase III, randomized, double-blind study. Baulac M; Patten A; Giorgi L Epilepsia; 2014 Oct; 55(10):1534-43. PubMed ID: 25109239 [TBL] [Abstract][Full Text] [Related]
20. [New possibilities of monotherapy of symptomatic and cryptogenic partial epilepsy]. Rudakova IG; Belova YA Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(5):115-119. PubMed ID: 26438905 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]